Supplementary table S3. Comparison of the current study with other reports of CGD from other countries

Centre / No of patients / Age at onset of infections / Age at diagnosis of CGD / XR: AR / Follow up / Number of episodes / No. of Aspergillus isolates (%) / No. of Staphylococcus isolates (%) / Mortality / Comments
Pneumonia / Lymphadenitis / Liver abscess / Osteomyelitis
US (2000) (3) / 368 / - / Mean age XR:AR was 3:7.8 years / 259:81 / - / 290 (79%) / 194 (53%) / 98 (27%) / 90 (25%) / 120 (40%) (In pneumonia alone) / 34 (11.3%) (In pneumonia alone) / 17.6% / Pseudomonas spp. accounted for 3% among organisms causing pneumonia
UK (2008) (6) / 94 / - / Median: 2.7 years (0-51.1) / 69:16 / - / 105 (52.13%) / 104 (40.43%) / 79 (28.72%) / 17 (11.7%) / 20 / 50 / 58.5% / 1 episode of Pseudomonas gladioli septicemia
Italy (2008) (7) / 60 / 7.5 months (0-10 yrs) / 4.4 years (mean) / 39:6 / 10.4 years (mean) / 45 (42.5%) / 21 (18%) / 12 (21%) / 5 (8.5%) / 16 (32%) / 10 (20%) / 13% / Pseudomonas spp. isolated in 1 patient with pneumonia
Japan (2008) (8) / 23 / - / 2.8 years (0.7-10) / 18:4 / 14.9 years (mean) / 81 / 31 / 8 / 14 / 21 / - / 13% / -
Sweden (1995) (9) / 21 / 2.5 yrs (range: 0-15) / 11.2 yrs (range:0.1-40) / 12:9 / - / 73 (90%) / 82 (90%) / 25 (38%) / 16 (33%) / 7 (5.8%) / 41 (34.17%) / 14.3% / -
Spain (2007) (10) / 13 / - / Median: 3 yrs (3, 137 months) / - / - / 10 / 12 / - / 3 / 10 (20.4%) / 7 (14.3%) / 30.77% / 4 isolates of Pseudomonas aeruginosa were identified (8.16%)
Iran (2011) (13) / 93 / Median age XL:AR was 5 months: 20 months / Median age XL:AR was 11:70 months / 12:81 / - / 57% / 65.6% / - / - / 17 (27%) / 10 (15.9%) / 9.7% / Mycobacterium was isolated in 23.8% patients. 17 cases had complications due to BCG
Turkey (2013) (11) / 89 / - / Mean 4.24 yrs (± 0.45) / 34:55 / - / 74 (83.6%) / 58 (65.17%) / 21 (23.16%) / - / 32 (50.8%) / 20 (31.7%) / 10.1% / 22.5% patients had BCG related complications
China (2014) (14) / 38 / Mean: 3.4 months (2 days-18 months) / Mean: 31.7 months (18 days-172 months) / - / - / 84.2% / 42.1% / - / - / - / - / - / 44.7% cases had BCG related complications
Israel (2008) (15) / 38 / Mean: 2.1±0.7 yrs / Mean: 5.8±1.3 yrs / 11:24 / - / 84% / 61% / 63% / 29% / 39% / 45% / 26% / Salmonella spp. and Pseudomonas sp. isolated in 21% and 13% resp.
Latin America (2015) (16) / 71 / Mean: 23.9 months (0.13-156) / Mean: 52.7 months (1-199) / 53:18 / - / 76.8% / - / - / 15.9% / 13% / 20.3% / nil / 30% children had adverse reactions to BCG
India (2016) (current study) / 38 / Median: 5 months (2-21) / Median: 2 yrs (0.7-4.5) / 16:18 / Median: 2 yrs (0.75-6) / 84 (94.7%) / 36 (52.6%) / 6 (13.2%) / 3 (8.1%) / 7 (18.4%) / 12 (31.6%) / 28.9% / 3 children with BCGitis. 6 isolates of Pseudomonas spp. (15.7%)